ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q3 2020 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR) Q3 2020 Earnings Conference Call November 3, 2020 16:30 ET Company Participants Tierney Saccavino - Executive Vice President, Corporate Communications Ron Cohen - Founder, Chief Executive Officer & President Conference Call Participants Philip Nadeau - Cowen & Company Presentation Operator Welcome to Acorda Therapeutics Third Quarter 2020 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised, that this call is being taped at the company's request. I will now introduce your host for today's call, Tierney Saccavino, Executive Vice President, Corporate Communications at Acorda. Please go ahead. Tierney Saccavino Thank you. Good afternoon, everyone. Before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public, and we encourage you to refer to those filings. I
For further details see:
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2020 Results - Earnings Call Transcript